-+ 0.00%
-+ 0.00%
-+ 0.00%

Kymera Therapeutics To Announce Results From Its Phase 1 Clinical Trial Evaluating Single And Multiple-Ascending Doses Of KT-579 In Healthy Volunteers On October 29

Benzinga·10/28/2026 20:03:57
Listen to the news

Announcement as part of its previously scheduled third quarter 2026 financial results. The Company will host a video conference call and webcast at 8:30 a.m. ET that day.